A Comprehensive Guide to Ordering Gefitinib (250mg) Online

Gefitinib (250mg)

Gefitinib 250 mg is an advanced targeted therapy used in the treatment of certain types of non-small cell lung cancer (NSCLC). Branded as GEFISTERIS 250, this tablet works by inhibiting specific proteins responsible for cancer cell growth. If you are prescribed gefitinib 250 mg, understanding its uses, mechanism of action, dosage, and potential side effects is essential. This guide provides a comprehensive, patient-friendly overview for safe and effective use.

What is Gefitinib 250 mg?

Gefitinib 250 mg is an oral medication classified as an epidermal growth factor receptor (EGFR) inhibitor. It targets and blocks the EGFR protein that promotes cancer cell growth, effectively slowing tumor progression in patients with NSCLC. GEFISTERIS 250 is used in patients with specific EGFR mutations and is a cornerstone of precision oncology therapy.

Gefitinib Drug Class

Gefitinib belongs to the tyrosine kinase inhibitor (TKI) class. These drugs are designed to selectively block enzymes involved in the signaling pathways that cause cancer cell proliferation. By doing so, gefitinib 250 mg helps control tumor growth and improves patient outcomes.

How Gefitinib Works

The mechanism of action of gefitinib includes:

• Blocking EGFR tyrosine kinase, which is overactive in certain lung cancers

• Inhibiting cell signaling pathways that promote cancer cell division and survival

• Slowing down tumor growth and reducing cancer progression

• Targeting EGFR-mutated NSCLC with precision therapy

Through these actions, gefitinib 250 mg tablet provides an effective targeted approach for managing NSCLC with fewer effects on healthy cells compared to traditional chemotherapy.

Uses of Gefitinib 250 mg Tablet

• First-line treatment for EGFR mutation-positive NSCLC

• Second-line therapy for patients who have progressed on other treatments

• Helps shrink tumors and control cancer symptoms

• Improves quality of life in patients with advanced lung cancer

Dosage of Gefitinib 250 mg

• The standard dose for adults: 250 mg orally once daily

• Tablets should be taken at the same time each day, with or without food

• Do not crush or chew GEFISTERIS 250; swallow whole with water

• Always follow your doctor’s instructions and never change your dose independently

Gefitinib Side Effects

Gefitinib 250 are generally well-tolerated. Common side effects may include:

• Diarrhea

• Skin rash or acne-like eruptions

• Nausea or vomiting

• Loss of appetite

• Fatigue

Serious side effects are rare but may include liver toxicity, interstitial lung disease (ILD), or severe allergic reactions. Contact your doctor immediately if you experience unusual symptoms.

Why Choose Steris Healthcare?

At Steris Healthcare, we prioritize quality, safety, and patient well-being. GEFISTERIS 250 is manufactured under WHO-GMP certified facilities, ensuring consistent potency, purity, and efficacy. Steris Healthcare provides reliable and affordable cancer medications trusted by doctors and patients across India.

Frequently Asked Questions

1. Can gefitinib cure cancer?

Gefitinib 250 mg is not a cure but is highly effective in controlling EGFR mutation-positive NSCLC. It slows tumor growth, reduces symptoms, and improves survival rates.

2. How long does it take to work?

Some patients may notice symptom improvement within weeks, but full therapeutic effects on tumor size may take months, monitored through imaging and doctor evaluations.

3. Can gefitinib be taken long term?

Yes, it is used as a long-term targeted therapy under medical supervision to maintain cancer control.

4. Can it be combined with other medications?

Gefitinib may interact with certain drugs, including antacids, proton pump inhibitors, or other cancer medications. Always inform your doctor about all medications you are taking.

5. Is gefitinib safe for elderly patients?

Yes, gefitinib 250 mg is generally safe for elderly patients with proper monitoring of liver function, lung health, and overall tolerance.

Conclusion

Gefitinib 250 mg, available as GEFISTERIS 250 from Steris Healthcare, is a vital option for patients with EGFR mutation-positive NSCLC. It offers targeted cancer treatment with manageable side effects and proven efficacy. Patients should consult their oncologist for personalized treatment advice and follow all medical instructions closely.

If you or a loved one is considering gefitinib 250 mg therapy, trust GEFISTERIS 250 by Steris Healthcare for quality, affordability, and expert support. Speak to your healthcare professional today to learn more or to get your prescription started.